Skip to main content
. 2020 May 12;10:7832. doi: 10.1038/s41598-020-64828-1

Figure 9.

Figure 9

In vivo efficacy studies. (A) Change of tumor volume demonstrates the inhibition of BJAB bearing SCID mice xenograft. (DOX 9 mg/kg). (B) Growth rate of tumor volume demonstrated the inhibition of BJAB bearing SCID mice xenograft. (DOX 9 mg/kg). (C) Gross view and HE staining results of the tumors. (D) weight change rate of BJAB bearing SCID mice during treatment. (A,B) One-way ANOVA test, between groups, *indicates P < 0.05, **indicates P < 0.001. (D) Due to the death on the 12th day, the mice died, so the weight change analysis, the data was weighed until the 10th day. After one-way analysis of variance, each treatment group and the control group were compared. **Indicates P < 0.01, ***indicates P < 0.001 when compared with the treatment group. *Indicates P < 0.05. When the DOX group was compared with the L-DOX group, P = 0.013, and the DOX group also decreased compared with the L-DOX + CUR group, P = 0.016.